Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Liquidia CorpLQDA · Entity 1860 | Chief Medical Officer | October 09, 2026 | October 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Liquidia Corp
Report date October 09, 2026 · Filed October 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 126,368 |
Last balance in matching sequence
After 2026-10-12 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2026-10-09 · Exercise / conversion · Acquired 3,530 · Balance 131,100 F2: On January 11, 2024, the Reporting Person was granted 56,492 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2025 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 38,838 have vested as of the date of this Form 4. F1: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3: Includes (i) 5,208 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 17,654 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 40,376 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 3,054 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Row 2 · 2026-10-09 · Exercise / conversion · Acquired 4,486 · Balance 135,586 F4: On January 11, 2025, the Reporting Person was granted 71,780 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2026 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 31,404 have vested as of the date of this Form 4. F1: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3: Includes (i) 5,208 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 17,654 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 40,376 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 3,054 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Row 3 · 2026-10-12 · Sale · Disposed 9,218 · Balance 126,368 F5: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F6: These shares of common stock were sold to cover taxes associated with the settlement of RSUs and PSUs that were initially granted to the Reporting Person on January 11, 2023, January 11, 2024 and January 11, 2025. F1: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3: Includes (i) 5,208 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 17,654 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 40,376 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 3,054 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 17,654 |
Reported balance
After 2026-10-09 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-10-09 · Exercise / conversion · Disposed 3,530 · Balance 17,654 F1: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 40,376 |
Reported balance
After 2026-10-09 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-10-09 · Exercise / conversion · Disposed 4,486 · Balance 40,376 F1: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 15,099 |
Reported balance
Holding disclosure · report date 2026-10-09 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 15,099 F7: The securities are held by Saggar Legacy Trust ("Trust"). The Reporting Person is the trustee of the Trust. |
Filing footnotes · ownership attribution and instrument terms
F1: Performance stock units ("PSUs") convert into common stock on a one-for-one basis.
F2: On January 11, 2024, the Reporting Person was granted 56,492 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2025 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 38,838 have vested as of the date of this Form 4.
F3: Includes (i) 5,208 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 17,654 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 40,376 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 3,054 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.
F4: On January 11, 2025, the Reporting Person was granted 71,780 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2026 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 31,404 have vested as of the date of this Form 4.
F5: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023.
F6: These shares of common stock were sold to cover taxes associated with the settlement of RSUs and PSUs that were initially granted to the Reporting Person on January 11, 2023, January 11, 2024 and January 11, 2025.
F7: The securities are held by Saggar Legacy Trust ("Trust"). The Reporting Person is the trustee of the Trust.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 12, 2026 Filed Oct 14, 2026 00:04 UTC | Liquidia Corp LQDA · Entity 1860 | SaleCommon Stock | 9,218 | $28.48 | $262,528.64 |
DisclosureSEC source: 0001104659-26-115649 · tm2627530-8_4seq1.xml · nonDerivative · entry 3 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 126,368 F5 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F6 · shares: These shares of common stock were sold to cover taxes associated with the settlement of RSUs and PSUs that were initially granted to the Reporting Person on January 11, 2023, January 11, 2024 and January 11, 2025. F1 · price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3 · balance_after: Includes (i) 5,208 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 17,654 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 40,376 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 3,054 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| October 09, 2026 Filed Oct 14, 2026 00:04 UTC | Liquidia Corp LQDA · Entity 1860 | Exercise / conversionPerformance Stock Units · Derivative | 4,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-115649 · tm2627530-8_4seq1.xml · derivative · entry 6 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,376 Underlying: Common Stock · 4,480 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.expiration_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. Read SEC document |
| October 09, 2026 Filed Oct 14, 2026 00:04 UTC | Liquidia Corp LQDA · Entity 1860 | Exercise / conversionPerformance Stock Units · Derivative | 3,530 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-115649 · tm2627530-8_4seq1.xml · derivative · entry 5 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,654 Underlying: Common Stock · 3,530 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.expiration_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. Read SEC document |
| October 09, 2026 Filed Oct 14, 2026 00:04 UTC | Liquidia Corp LQDA · Entity 1860 | Exercise / conversionCommon Stock | 4,486 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-115649 · tm2627530-8_4seq1.xml · nonDerivative · entry 2 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 135,586 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: On January 11, 2025, the Reporting Person was granted 71,780 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2026 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 31,404 have vested as of the date of this Form 4. F1 · price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3 · balance_after: Includes (i) 5,208 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 17,654 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 40,376 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 3,054 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| October 09, 2026 Filed Oct 14, 2026 00:04 UTC | Liquidia Corp LQDA · Entity 1860 | Exercise / conversionCommon Stock | 3,530 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-115649 · tm2627530-8_4seq1.xml · nonDerivative · entry 1 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 131,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On January 11, 2024, the Reporting Person was granted 56,492 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2025 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 38,838 have vested as of the date of this Form 4. F1 · price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3 · balance_after: Includes (i) 5,208 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 17,654 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 40,376 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 3,054 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| August 19, 2026 Filed Aug 19, 2026 22:21 UTC | Liquidia Corp LQDA · Entity 1860 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $3.73 | $0.00 |
DisclosureSEC source: 0001104659-26-098862 · tm2623646-1_4seq1.xml · derivative · entry 4 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 50,000 shares Expires 2032-07-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vested over a four-year period with 25% vesting on July 18, 2023 and the remaining 75% vesting ratably on a monthly basis over three years thereafter and became fully vested on July 18, 2026. Read SEC document |
| August 19, 2026 Filed Aug 19, 2026 22:21 UTC | Liquidia Corp LQDA · Entity 1860 | SaleCommon Stock | 50,000 | $74.06 | $3,702,825.00 |
DisclosureSEC source: 0001104659-26-098862 · tm2623646-1_4seq1.xml · nonDerivative · entry 3 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,265 F3 · kind: Represents the subsequent sale of the underlying shares from the exercise of stock options reported on this Form 4. F4 · price: Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $74.00 to $74.60. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes (i) 10,416 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 21,184 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 44,862 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,650 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| August 19, 2026 Filed Aug 19, 2026 22:21 UTC | Liquidia Corp LQDA · Entity 1860 | Exercise / conversionCommon Stock | 50,000 | $3.73 | $186,500.00 |
DisclosureSEC source: 0001104659-26-098862 · tm2623646-1_4seq1.xml · nonDerivative · entry 2 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,265 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Includes (i) 10,416 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 21,184 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 44,862 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,650 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| August 17, 2026 Filed Aug 19, 2026 22:21 UTC | Liquidia Corp LQDA · Entity 1860 | SaleCommon Stock | 29,534 | $76.84 | $2,269,380.75 |
DisclosureSEC source: 0001104659-26-098862 · tm2623646-1_4seq1.xml · nonDerivative · entry 1 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,265 F1 · price: Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $76.76 to $77.13. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes (i) 10,416 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 21,184 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 44,862 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,650 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| July 13, 2026 Filed Jul 15, 2026 00:02 UTC | Liquidia Corp LQDA · Entity 1860 | SaleCommon Stock | 9,223 | $71.52 | $659,628.96 |
DisclosureSEC source: 0001104659-26-083616 · tm2620529-3_4seq1.xml · nonDerivative · entry 4 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 171,799 F5 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F6 · shares: These shares of common stock were sold to cover taxes associated with the settlement of RSUs and PSUs that were initially granted to the Reporting Person on January 11, 2023, January 11, 2024 and January 11, 2025. F1 · price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3 · balance_after: Includes (i) 10,416 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 21,184 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 44,862 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,650 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| July 13, 2026 Filed Jul 15, 2026 00:02 UTC | Liquidia Corp LQDA · Entity 1860 | SaleCommon Stock | 703 | $71.39 | $50,187.17 |
DisclosureSEC source: 0001104659-26-083616 · tm2620529-3_4seq1.xml · nonDerivative · entry 3 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 181,022 F5 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F6 · shares: These shares of common stock were sold to cover taxes associated with the settlement of RSUs and PSUs that were initially granted to the Reporting Person on January 11, 2023, January 11, 2024 and January 11, 2025. F1 · price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3 · balance_after: Includes (i) 10,416 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 21,184 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 44,862 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,650 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| July 10, 2026 Filed Jul 15, 2026 00:02 UTC | Liquidia Corp LQDA · Entity 1860 | Exercise / conversionPerformance Stock Units · Derivative | 4,487 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-083616 · tm2620529-3_4seq1.xml · derivative · entry 6 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,862 Underlying: Common Stock · 4,487 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.expiration_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. Read SEC document |
| July 10, 2026 Filed Jul 15, 2026 00:02 UTC | Liquidia Corp LQDA · Entity 1860 | Exercise / conversionPerformance Stock Units · Derivative | 3,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-083616 · tm2620529-3_4seq1.xml · derivative · entry 5 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,184 Underlying: Common Stock · 3,531 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.expiration_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. Read SEC document |
| July 10, 2026 Filed Jul 15, 2026 00:02 UTC | Liquidia Corp LQDA · Entity 1860 | Exercise / conversionCommon Stock | 4,487 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-083616 · tm2620529-3_4seq1.xml · nonDerivative · entry 2 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 181,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: On January 11, 2025, the Reporting Person was granted 71,780 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2026 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 26,918 have vested as of the date of this Form 4. F1 · price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3 · balance_after: Includes (i) 10,416 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 21,184 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 44,862 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,650 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| July 10, 2026 Filed Jul 15, 2026 00:02 UTC | Liquidia Corp LQDA · Entity 1860 | Exercise / conversionCommon Stock | 3,531 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-083616 · tm2620529-3_4seq1.xml · nonDerivative · entry 1 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 177,238 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On January 11, 2024, the Reporting Person was granted 56,492 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2025 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 35,308 have vested as of the date of this Form 4. F1 · price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3 · balance_after: Includes (i) 10,416 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 21,184 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 44,862 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,650 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| April 13, 2026 Filed Apr 14, 2026 21:06 UTC | Liquidia Corp LQDA · Entity 1860 | SaleCommon Stock | 9,220 | $38.37 | $353,771.40 |
DisclosureSEC source: 0001104659-26-043265 · tm2611789-3_4seq1.xml · nonDerivative · entry 3 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 173,270 F5 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F6 · shares: These shares of common stock were sold to cover taxes associated with the settlement of RSUs and PSUs that were initially granted to the Reporting Person on January 11, 2023, January 11, 2024 and January 11, 2025. F1 · price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3 · balance_after: Includes (i) 15,625 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 24,715 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 49,349 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,213 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 21:06 UTC | Liquidia Corp LQDA · Entity 1860 | Exercise / conversionPerformance Stock Units · Derivative | 4,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-043265 · tm2611789-3_4seq1.xml · derivative · entry 5 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,349 Underlying: Common Stock · 4,486 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.expiration_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 21:06 UTC | Liquidia Corp LQDA · Entity 1860 | Exercise / conversionPerformance Stock Units · Derivative | 3,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-043265 · tm2611789-3_4seq1.xml · derivative · entry 4 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,715 Underlying: Common Stock · 3,531 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.expiration_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 21:06 UTC | Liquidia Corp LQDA · Entity 1860 | Exercise / conversionCommon Stock | 4,486 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-043265 · tm2611789-3_4seq1.xml · nonDerivative · entry 2 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 182,490 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: On January 11, 2025, the Reporting Person was granted 71,780 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2026 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 22,431 have vested as of the date of this Form 4. F1 · price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3 · balance_after: Includes (i) 15,625 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 24,715 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 49,349 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,213 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 21:06 UTC | Liquidia Corp LQDA · Entity 1860 | Exercise / conversionCommon Stock | 3,531 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-043265 · tm2611789-3_4seq1.xml · nonDerivative · entry 1 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 178,004 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On January 11, 2024, the Reporting Person was granted 56,492 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2025 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 31,777 have vested as of the date of this Form 4. F1 · price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3 · balance_after: Includes (i) 15,625 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 24,715 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 49,349 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,213 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 20:31 UTC | Liquidia Corp LQDA · Entity 1860 | SaleCommon Stock | 35,365 | $36.30 | $1,283,834.38 |
DisclosureSEC source: 0001104659-26-029532 · tm269072-3_4seq1.xml · nonDerivative · entry 1 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,473 F1 · price: Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $36.29 to $36.45. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes (i) 20,833 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 28,246 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 53,835 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,213 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 23:16 UTC | Liquidia Corp LQDA · Entity 1860 | GrantPerformance Stock Units · Derivative | 49,433 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-005476 · tm263781-2_4seq1.xml · derivative · entry 2 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,433 Underlying: Common Stock · 49,433 shares Expires not disclosed F4 · derivative.exercise_price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: On January 16, 2026, the Reporting Person was granted 49,433 PSUs which vest upon the following time-based vesting schedule: (i) 25% of the PSUs shall vest on the Initial Vesting Date or, if later, the date on which the Issuer files its Form 10-K for the fiscal year ending December 31, 2026 (the "FY2026 10-K") and (ii) 6.25% of the PSUs vesting every three months following the Initial Vesting Date; so long as it satisfies the milestone-based vesting condition: the applicable percentage of the RSUs vesting based on net product sales revenue from YUTREPIA in 2026 as disclosed in the Issuer's FY2026 10-K. F5 · derivative.expiration_date: On January 16, 2026, the Reporting Person was granted 49,433 PSUs which vest upon the following time-based vesting schedule: (i) 25% of the PSUs shall vest on the Initial Vesting Date or, if later, the date on which the Issuer files its Form 10-K for the fiscal year ending December 31, 2026 (the "FY2026 10-K") and (ii) 6.25% of the PSUs vesting every three months following the Initial Vesting Date; so long as it satisfies the milestone-based vesting condition: the applicable percentage of the RSUs vesting based on net product sales revenue from YUTREPIA in 2026 as disclosed in the Issuer's FY2026 10-K. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 23:16 UTC | Liquidia Corp LQDA · Entity 1860 | GrantCommon Stock | 32,955 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-005476 · tm263781-2_4seq1.xml · nonDerivative · entry 1 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 209,838 F1 · kind: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F2 · shares: (i) 25% of the RSUs shall vest on January 11, 2027 (the "Initial Vesting Date") and (ii) 6.25% of the RSUs vesting every three months following the Initial Vesting Date. F3 · balance_after: Includes (i) 20,833 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 28,246 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 53,835 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,213 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| January 12, 2026 Filed Jan 13, 2026 21:31 UTC | Liquidia Corp LQDA · Entity 1860 | SaleCommon Stock | 21,142 | $37.43 | $791,345.06 |
DisclosureSEC source: 0001104659-26-003361 · tm263060-1_4seq1.xml · nonDerivative · entry 3 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 176,883 F5 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F6 · shares: These shares of common stock were sold to cover taxes associated with the settlement of RSUs that were initially granted to the Reporting Person on January 11, 2023, January 11, 2024 and January 11, 2025. F3 · balance_after: Includes (i) 20,833 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 28,246 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 53,835 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025 and (iv) 2,221 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| January 09, 2026 Filed Jan 13, 2026 21:31 UTC | Liquidia Corp LQDA · Entity 1860 | Exercise / conversionPerformance Stock Units · Derivative | 17,945 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-003361 · tm263060-1_4seq1.xml · derivative · entry 5 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,835 Underlying: Common Stock · 17,945 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.expiration_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. Read SEC document |
| January 09, 2026 Filed Jan 13, 2026 21:31 UTC | Liquidia Corp LQDA · Entity 1860 | Exercise / conversionPerformance Stock Units · Derivative | 3,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-003361 · tm263060-1_4seq1.xml · derivative · entry 4 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,246 Underlying: Common Stock · 3,531 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.expiration_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. Read SEC document |
| January 09, 2026 Filed Jan 13, 2026 21:31 UTC | Liquidia Corp LQDA · Entity 1860 | Exercise / conversionCommon Stock | 17,945 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-003361 · tm263060-1_4seq1.xml · nonDerivative · entry 2 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 198,025 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: On January 11, 2025, the Reporting Person was granted 71,780 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2026 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 17,945 have vested as of the date of this Form 4. F1 · price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3 · balance_after: Includes (i) 20,833 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 28,246 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 53,835 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025 and (iv) 2,221 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| January 09, 2026 Filed Jan 13, 2026 21:31 UTC | Liquidia Corp LQDA · Entity 1860 | Exercise / conversionCommon Stock | 3,531 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-003361 · tm263060-1_4seq1.xml · nonDerivative · entry 1 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 180,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On January 11, 2024, the Reporting Person was granted 56,492 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2025 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 28,246 have vested as of the date of this Form 4. F1 · price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3 · balance_after: Includes (i) 20,833 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 28,246 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 53,835 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025 and (iv) 2,221 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| November 05, 2025 Filed Nov 7, 2025 21:30 UTC | Liquidia Corp LQDA · Entity 1860 | SaleCommon Stock | 66,463 | $27.00 | $1,794,501.00 |
DisclosureSEC source: 0001104659-25-108512 · tm2530541-1_4seq1.xml · nonDerivative · entry 2 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,549 F1 · balance_after: Includes (i) 26,041 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 31,777 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 71,780 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4, and (iv) 2,221 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| November 05, 2025 Filed Nov 7, 2025 21:30 UTC | Liquidia Corp LQDA · Entity 1860 | SaleCommon Stock | 4,918 | $27.00 | $132,786.00 |
DisclosureSEC source: 0001104659-25-108512 · tm2530541-1_4seq1.xml · nonDerivative · entry 1 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 243,012 F1 · balance_after: Includes (i) 26,041 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 31,777 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 71,780 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4, and (iv) 2,221 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| October 13, 2025 Filed Oct 15, 2025 20:33 UTC | Liquidia Corp LQDA · Entity 1860 | SaleCommon Stock | 5,327 | $23.41 | $124,705.07 |
DisclosureSEC source: 0001104659-25-099750 · tm2528808-5_4seq1.xml · nonDerivative · entry 2 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 247,930 F4 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F5 · shares: These shares were sold to cover taxes associated with the settlement of RSUs and PSUs that were initially granted to the Reporting Person on January 11, 2023 and January 11, 2024. F3 · balance_after: Includes (i) 26,041 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 31,777 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 71,780 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4, and (iv) 7,139 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| October 10, 2025 Filed Oct 15, 2025 20:33 UTC | Liquidia Corp LQDA · Entity 1860 | Exercise / conversionPerformance Stock Units · Derivative | 3,530 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-099750 · tm2528808-5_4seq1.xml · derivative · entry 3 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,777 Underlying: Common Stock · 3,530 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.expiration_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. Read SEC document |
| October 10, 2025 Filed Oct 15, 2025 20:33 UTC | Liquidia Corp LQDA · Entity 1860 | Exercise / conversionCommon Stock | 3,530 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-099750 · tm2528808-5_4seq1.xml · nonDerivative · entry 1 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 253,257 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On January 11, 2024, the Reporting Person was granted 56,492 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2025 and the remaining PSUs vesting ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 24,715 have vested as of the date of this Form 4. F1 · price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3 · balance_after: Includes (i) 26,041 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 31,777 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 71,780 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4, and (iv) 7,139 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| August 28, 2025 Filed Sep 2, 2025 21:02 UTC | Liquidia Corp LQDA · Entity 1860 | SaleCommon Stock | 20,000 | $27.85 | $557,072.00 |
DisclosureSEC source: 0001104659-25-086436 · tm2525033-1_4seq1.xml · nonDerivative · entry 1 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 249,727 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 29, 2025. F2 · price: Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $27.22 to $28.53. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes (i) 31,249 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 35,307 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 71,780 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4, and (iv) 7,131 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| July 21, 2025 Filed Jul 23, 2025 20:30 UTC | Liquidia Corp LQDA · Entity 1860 | SaleCommon Stock | 2,526 | $14.54 | $36,728.04 |
DisclosureSEC source: 0001104659-25-070027 · tm2521410-1_4seq1.xml · nonDerivative · entry 1 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 268,887 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F2 · shares: These shares were sold to cover taxes associated with the settlement of restricted stock units ("RSUs") that were initially granted to the Reporting Person on July 18, 2022. F3 · balance_after: Includes (i) 31,249 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 35,307 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 71,780 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4, and (iv) 6,291 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| July 14, 2025 Filed Jul 15, 2025 20:36 UTC | Liquidia Corp LQDA · Entity 1860 | SaleCommon Stock | 5,327 | $14.28 | $76,069.56 |
DisclosureSEC source: 0001104659-25-068123 · tm2520991-7_4seq1.xml · nonDerivative · entry 2 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 271,413 F4 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F5 · shares: These shares were sold to cover taxes associated with the settlement of RSUs and PSUs that were initially granted to the Reporting Person on January 11, 2023 and January 11, 2024. F3 · balance_after: Includes (i) 5,865 unvested restricted stock units ("RSUs") of the 93,834 RSUs granted to the Reporting Person on July 18, 2022, (ii) 31,249 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (iii) 35,307 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iv) 71,780 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4, and (v) 6,291 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| July 11, 2025 Filed Jul 15, 2025 20:36 UTC | Liquidia Corp LQDA · Entity 1860 | Exercise / conversionPerformance Stock Units · Derivative | 3,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-068123 · tm2520991-7_4seq1.xml · derivative · entry 3 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,307 Underlying: Common Stock · 3,531 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.expiration_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. Read SEC document |
| July 11, 2025 Filed Jul 15, 2025 20:36 UTC | Liquidia Corp LQDA · Entity 1860 | Exercise / conversionCommon Stock | 3,531 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-068123 · tm2520991-7_4seq1.xml · nonDerivative · entry 1 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 276,740 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On January 11, 2024, the Reporting Person was granted 56,492 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2025 and the remaining PSUs vesting ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 21,185 have vested as of the date of this Form 4. F1 · price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3 · balance_after: Includes (i) 5,865 unvested restricted stock units ("RSUs") of the 93,834 RSUs granted to the Reporting Person on July 18, 2022, (ii) 31,249 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (iii) 35,307 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iv) 71,780 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4, and (v) 6,291 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| June 04, 2025 Filed Jun 5, 2025 20:19 UTC | Liquidia Corp LQDA · Entity 1860 | SaleCommon Stock | 7,597 | $16.97 | $128,921.09 |
DisclosureSEC source: 0001104659-25-056855 · tm2517227-5_4seq1.xml · nonDerivative · entry 2 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 273,209 F4 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F5 · shares: These shares were sold to cover taxes associated with the settlement of PSUs that were initially granted to the Reporting Person on January 11, 2024. F3 · balance_after: Includes (i) 5,865 unvested restricted stock units ("RSUs") of the 93,834 RSUs granted to the Reporting Person on July 18, 2022, (ii) 36,458 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (iii) 38,838 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iv) 71,780 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested, and (v) 6,291 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:19 UTC | Liquidia Corp LQDA · Entity 1860 | Exercise / conversionPerformance Stock Units · Derivative | 17,654 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-056855 · tm2517227-5_4seq1.xml · derivative · entry 3 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,838 Underlying: Common Stock · 17,654 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.expiration_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:19 UTC | Liquidia Corp LQDA · Entity 1860 | Exercise / conversionCommon Stock | 17,654 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-056855 · tm2517227-5_4seq1.xml · nonDerivative · entry 1 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 280,806 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On January 11, 2024, the Reporting Person was granted 56,492 PSUs which vest upon the later of (A) the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2025 and the remaining PSUs vesting ratably on a quarterly basis over three years thereafter and (B) the first commercial sale of YUTREPIA by the Issuer. Of those PSUs, a total of 17,654 have vested through June 3, 2025. F1 · price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3 · balance_after: Includes (i) 5,865 unvested restricted stock units ("RSUs") of the 93,834 RSUs granted to the Reporting Person on July 18, 2022, (ii) 36,458 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (iii) 38,838 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iv) 71,780 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested, and (v) 6,291 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| April 21, 2025 Filed Apr 23, 2025 20:15 UTC | Liquidia Corp LQDA · Entity 1860 | SaleCommon Stock | 2,450 | $13.67 | $33,491.50 |
DisclosureSEC source: 0001104659-25-038008 · tm2512894-1_4seq1.xml · nonDerivative · entry 1 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 263,152 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F2 · shares: These shares of common stock were sold to cover taxes associated with the settlement of restricted stock units ("RSUs") that were initially granted to the Reporting Person on July 18, 2022 and vested on April 21, 2025. F3 · balance_after: Includes (i) 5,865 unvested RSUs of the 93,834 RSUs granted to the Reporting Person on July 18, 2022, (ii) 36,458 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (iii) 38,838 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iv) 71,780 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested, and (v) 6,291 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| April 14, 2025 Filed Apr 16, 2025 21:02 UTC | Liquidia Corp LQDA · Entity 1860 | SaleCommon Stock | 3,714 | $13.57 | $50,398.98 |
DisclosureSEC source: 0001104659-25-035543 · tm2512499-1_4seq1.xml · nonDerivative · entry 1 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 265,602 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F2 · shares: These shares of common stock were sold to cover taxes associated with the settlement of restricted stock units ("RSUs") that were initially granted to the Reporting Person on January 11, 2023 and vested on April 14, 2025. F3 · balance_after: Includes (i) 11,729 unvested RSUs of the 93,834 RSUs granted to the Reporting Person on July 18, 2022, (ii) 36,458 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (iii) 38,838 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iv) 71,780 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested, and (v) 6,291 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| January 21, 2025 Filed Jan 23, 2025 22:00 UTC | Liquidia Corp LQDA · Entity 1860 | SaleCommon Stock | 2,445 | $13.00 | $31,785.00 |
DisclosureSEC source: 0001104659-25-005669 · tm254201-1_4seq1.xml · nonDerivative · entry 1 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 267,943 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F2 · shares: These shares of common stock were sold to cover taxes associated with the settlement of restricted stock units ("RSUs") that were initially granted to the Reporting Person on July 18, 2022 and vested on January 18, 2025. F3 · balance_after: Includes (i) 11,729 unvested RSUs of the 93,834 RSUs granted to the Reporting Person on July 18, 2022, (ii) 41,666 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (iii) 42,369 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iv) 71,780 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested, and (v) 4,918 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| January 14, 2025 Filed Jan 14, 2025 21:39 UTC | Liquidia Corp LQDA · Entity 1860 | SaleCommon Stock | 6,249 | $11.78 | $73,613.22 |
DisclosureSEC source: 0001104659-25-003475 · tm253294-5_4seq1.xml · nonDerivative · entry 2 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 270,388 F4 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F5 · shares: These shares of common stock were sold to cover taxes associated with the settlement of RSUs that were initially granted to the Reporting Person on January 11, 2023 and January 11, 2024. F3 · balance_after: Includes (i) 17,594 unvested RSUs of the 93,834 RSUs granted to the Reporting Person on July 18, 2022, (ii) 41,666 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (iii) 42,369 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024 and (iv) 4,918 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| January 11, 2025 Filed Jan 14, 2025 21:39 UTC | Liquidia Corp LQDA · Entity 1860 | GrantPerformance Stock Units · Derivative | 71,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-003475 · tm253294-5_4seq1.xml · derivative · entry 3 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,780 Underlying: Common Stock · 71,780 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit ("PSU") converts into one share of the Issuer's common stock. F7 · derivative.exercise_date: On January 11, 2025, the Reporting Person was granted 71,780 PSUs. The PSUs shall vest upon the later of (A) the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2026 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter, and (B) the first commercial sale of YUTREPIA by the Issuer. F7 · derivative.expiration_date: On January 11, 2025, the Reporting Person was granted 71,780 PSUs. The PSUs shall vest upon the later of (A) the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2026 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter, and (B) the first commercial sale of YUTREPIA by the Issuer. Read SEC document |
| January 11, 2025 Filed Jan 14, 2025 21:39 UTC | Liquidia Corp LQDA · Entity 1860 | GrantCommon Stock | 71,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-003475 · tm253294-5_4seq1.xml · nonDerivative · entry 1 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 276,637 F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: 25% of the RSUs shall vest on January 11, 2026 and the remaining RSUs shall vest ratably on a quarterly basis over three years thereafter. F3 · balance_after: Includes (i) 17,594 unvested RSUs of the 93,834 RSUs granted to the Reporting Person on July 18, 2022, (ii) 41,666 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (iii) 42,369 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024 and (iv) 4,918 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| October 18, 2024 Filed Oct 22, 2024 20:15 UTC | Liquidia Corp LQDA · Entity 1860 | SaleCommon Stock | 2,526 | $11.19 | $28,265.94 |
DisclosureSEC source: 0001104659-24-110565 · tm2426648-1_4seq1.xml · nonDerivative · entry 1 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 204,857 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F2 · shares: These shares of common stock were sold to cover taxes associated with the settlement of restricted stock units ("RSUs") that were initially granted to the Reporting Person on July 18, 2022. F3 · balance_after: Includes (i) 17,594 unvested RSUs of the 93,834 RSUs granted to the Reporting Person on July 18, 2022, (ii) 46,874 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (iii) 56,492 RSUs granted to the Reporting Person on January 11, 2024, none of which have vested as of the date of this Form 4 and (iv) 4,918 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| October 14, 2024 Filed Oct 16, 2024 00:11 UTC | Liquidia Corp LQDA · Entity 1860 | SaleCommon Stock | 2,260 | $11.11 | $25,103.40 |
DisclosureSEC source: 0001104659-24-108768 · tm2426238-5_4seq1.xml · nonDerivative · entry 1 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 207,383 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F2 · shares: These shares of common stock were sold to cover taxes associated with the settlement of restricted stock units ("RSUs") that were initially granted to the Reporting Person on January 11, 2023. F3 · balance_after: Includes (i) 23,458 unvested RSUs of the 93,834 RSUs granted to the Reporting Person on July 18, 2022, (ii) 46,874 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (iii) 56,492 RSUs granted to the Reporting Person on January 11, 2024, none of which have vested as of the date of this Form 4 and (iv) 4,918 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| July 19, 2024 Filed Jul 22, 2024 20:30 UTC | Liquidia Corp LQDA · Entity 1860 | SaleCommon Stock | 1,873 | $11.13 | $20,846.49 |
DisclosureSEC source: 0001104659-24-081516 · tm2419910-1_4seq1.xml · nonDerivative · entry 1 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 208,329 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F2 · shares: These shares of common stock were sold to cover taxes associated with the settlement of restricted stock units ("RSUs") that were initially granted to the Reporting Person on July 18, 2022. F3 · balance_after: Includes (i) 23,458 unvested RSUs of the 93,834 RSUs granted to the Reporting Person on July 18, 2022, (ii) 52,082 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (iii) 56,492 RSUs granted to the Reporting Person on January 11, 2024, none of which have vested as of the date of this Form 4 and (iv) 3,604 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.